Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GBIO |
---|---|---|
09:32 ET | 437 | 3.05 |
09:41 ET | 749 | 3.03 |
10:01 ET | 200 | 3.07 |
10:08 ET | 100 | 3.08 |
10:10 ET | 129 | 3.0811 |
10:17 ET | 100 | 3.075 |
10:19 ET | 100 | 3.08 |
10:26 ET | 300 | 3.11 |
10:28 ET | 650 | 3.1499 |
10:32 ET | 258 | 3.107 |
10:35 ET | 229 | 3.07 |
10:37 ET | 100 | 3.095 |
10:39 ET | 100 | 3.07 |
10:44 ET | 100 | 3.095 |
10:51 ET | 100 | 3.08 |
11:20 ET | 100 | 3.05 |
11:24 ET | 100 | 3.08 |
11:27 ET | 100 | 3.075 |
11:36 ET | 100 | 3.07 |
11:38 ET | 4786 | 3.05 |
11:40 ET | 100 | 3.06 |
11:44 ET | 100 | 3.05 |
11:45 ET | 100 | 3.05 |
11:47 ET | 100 | 3.06 |
11:56 ET | 2053 | 3.0818 |
12:02 ET | 100 | 3.07 |
12:16 ET | 100 | 3.1 |
12:27 ET | 200 | 3.1 |
12:38 ET | 400 | 3.11 |
12:45 ET | 100 | 3.115 |
12:48 ET | 100 | 3.13 |
12:50 ET | 100 | 3.13 |
12:56 ET | 100 | 3.13 |
01:06 ET | 100 | 3.13 |
01:10 ET | 398 | 3.1268 |
01:14 ET | 1300 | 3.115 |
01:19 ET | 1526 | 3.13 |
01:24 ET | 300 | 3.13 |
01:32 ET | 100 | 3.13 |
01:35 ET | 2000 | 3.14 |
01:39 ET | 200 | 3.17 |
01:51 ET | 225 | 3.17 |
02:00 ET | 735 | 3.19 |
02:04 ET | 474 | 3.1501 |
02:06 ET | 6743 | 3.12 |
02:09 ET | 500 | 3.16 |
02:13 ET | 348 | 3.16 |
02:18 ET | 405 | 3.15 |
02:24 ET | 400 | 3.16 |
02:33 ET | 589 | 3.19 |
02:49 ET | 100 | 3.18 |
02:56 ET | 885 | 3.18 |
03:02 ET | 200 | 3.18 |
03:03 ET | 100 | 3.165 |
03:09 ET | 100 | 3.18 |
03:12 ET | 222 | 3.165 |
03:20 ET | 200 | 3.19 |
03:23 ET | 8292 | 3.11 |
03:25 ET | 100 | 3.13 |
03:30 ET | 1885 | 3.185 |
03:36 ET | 100 | 3.185 |
03:38 ET | 867 | 3.16 |
03:48 ET | 5824 | 3.11 |
03:50 ET | 100 | 3.12 |
03:52 ET | 300 | 3.13 |
03:54 ET | 137 | 3.12 |
03:56 ET | 100 | 3.12 |
03:57 ET | 1000 | 3.1 |
03:59 ET | 720 | 3.12 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Generation Bio Co | 211.6M | -1.2x | --- |
Quantum-Si Inc | 215.6M | -2.3x | --- |
Prelude Therapeutics Inc | 211.5M | -1.9x | --- |
Ovid Therapeutics Inc | 217.1M | -4.2x | --- |
Lineage Cell Therapeutics Inc | 188.8M | -7.2x | --- |
Invivyd Inc | 219.5M | -1.0x | --- |
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $211.6M |
---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 66.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.87 |
EPS | $-2.56 |
Book Value | $3.07 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 21.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,820.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.